Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment
Significant barriers still exist despite established safety profiles, such as high costs that restrict access worldwide, a lack of predictive biomarkers for treatment response, a lack of knowledge about the mechanistics of gut microbiota interactions, and an incomplete understanding of long-term safety, particularly with regard to thyroid and pancreatic effects
Vyvanse Young Adult (18-29) Safety: What the Evidence Shows At a glance FDA approval / ADHD and binge eating disorder (BED) in adults, including ages 18-29 Prodrug design / converted to d-amphetamine in red blood cells, limiting intranasal or IV misuse Standard dose range / 30-70 mg once daily (morning administration) Most common side effects / decreased appetite, insomnia, dry mouth, increased heart rate Cardiovascular signal / mean heart rate increase of 2-6 bpm
Well, I knew this going into the research for the book that, so what I didn't realize is that through, okay, 1797 is when the sort of first accepted successful treatment of a case of diabetes